Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mario Boccadoro
A Simple Score, Based on Geriatric Assessment, Improves Prediction of Survival, and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Prospective Molecular Monitoring of Minimal Residual Disease After Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Minimal Residual Disease by Flow Cytometry and Allelic-Specific Oligonucleotide Real-Time Quantitative Polymerase Chain Reaction in Patients With Myeloma Receiving Lenalidomide Maintenance: A Pooled Analysis
Cancer
Cancer Research
Oncology
First-Line Therapy With Either Bortezomib-Melphalan-Prednisone or Lenalidomide-Dexamethasone Followed by Lenalidomide for Transplant-Ineligible Multiple Myeloma Patients: A Pooled Analysis of Two Randomized Trials
Haematologica
Hematology
HIF-1α Is Overexpressed in Leukemic Cells From TP53-disrupted Patients and Is a Promising Therapeutic Target in Chronic Lymphocytic Leukemia
Haematologica
Hematology
European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses
Oncologist
Cancer Research
Medicine
Oncology
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies
Cancers
Cancer Research
Oncology
Enduring Efficacy and Tolerability of Daratumumab in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma ( GEN 503): Final Results of an Open‐label, Phase 1/2 Study
British Journal of Haematology
Hematology
Long-Term Thymic Function and Reconstitution of the T Cell Compartment After T Cell-Replete Haplo-Identical Allografting
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Humoral Immune Responses Toward Tumor-Derived Antigens in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Oncotarget
Oncology
1
2
›